[go: up one dir, main page]

CL2007002760A1 - Metodo de estabilizacion de famotidina, que comprende realizarla en medios alcalinos con un ph superior a 8 mediante un proceso de microencapsulacion. - Google Patents

Metodo de estabilizacion de famotidina, que comprende realizarla en medios alcalinos con un ph superior a 8 mediante un proceso de microencapsulacion.

Info

Publication number
CL2007002760A1
CL2007002760A1 CL200702760A CL2007002760A CL2007002760A1 CL 2007002760 A1 CL2007002760 A1 CL 2007002760A1 CL 200702760 A CL200702760 A CL 200702760A CL 2007002760 A CL2007002760 A CL 2007002760A CL 2007002760 A1 CL2007002760 A1 CL 2007002760A1
Authority
CL
Chile
Prior art keywords
famotidine
perform
stabilization method
alkaline media
microencapsulation process
Prior art date
Application number
CL200702760A
Other languages
English (en)
Inventor
Armenta Maria Elena Alv Garcia
Original Assignee
Leopoldo De Jesus Espinosa Abd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leopoldo De Jesus Espinosa Abd filed Critical Leopoldo De Jesus Espinosa Abd
Publication of CL2007002760A1 publication Critical patent/CL2007002760A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CL200702760A 2006-09-25 2007-09-25 Metodo de estabilizacion de famotidina, que comprende realizarla en medios alcalinos con un ph superior a 8 mediante un proceso de microencapsulacion. CL2007002760A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA06010972A MXPA06010972A (es) 2006-09-25 2006-09-25 Proceso para estabilizacion de famotidina.

Publications (1)

Publication Number Publication Date
CL2007002760A1 true CL2007002760A1 (es) 2008-04-25

Family

ID=39230698

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200702760A CL2007002760A1 (es) 2006-09-25 2007-09-25 Metodo de estabilizacion de famotidina, que comprende realizarla en medios alcalinos con un ph superior a 8 mediante un proceso de microencapsulacion.

Country Status (8)

Country Link
EP (1) EP2085079A2 (es)
AR (1) AR062987A1 (es)
BR (1) BRPI0717425A2 (es)
CL (1) CL2007002760A1 (es)
CO (1) CO6160290A2 (es)
CR (1) CR10685A (es)
MX (1) MXPA06010972A (es)
WO (1) WO2008039052A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX351059B (es) * 2012-08-17 2017-09-29 Laboratorios Senosiain S A De C V Star Composicion farmaceutica oral en forma de microesferas y proceso de elaboracion.
CA3042466A1 (en) * 2016-11-01 2018-05-11 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form
KR102648960B1 (ko) * 2017-09-29 2024-03-20 존슨 앤드 존슨 컨수머 인코포레이티드 고체 시메티콘 입자 및 이의 투여 형태
US11433024B2 (en) 2018-04-27 2022-09-06 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form
CN112822998B (zh) 2018-10-18 2024-09-13 强生消费者公司 新型剂型
US20220331294A1 (en) * 2019-09-27 2022-10-20 Johnson & Johnson Consumer Inc. Gel-chewable dosage form

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021543A1 (en) * 1997-10-27 1999-05-06 Sumitomo Pharmaceuticals Co., Ltd. Amide derivatives
US20050053655A1 (en) * 2003-09-05 2005-03-10 Pharmaceutical Industry Technology And Development Center Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same

Also Published As

Publication number Publication date
WO2008039052A2 (es) 2008-04-03
WO2008039052A3 (es) 2008-06-19
EP2085079A2 (en) 2009-08-05
AR062987A1 (es) 2008-12-17
BRPI0717425A2 (pt) 2013-11-12
CO6160290A2 (es) 2010-05-20
MXPA06010972A (es) 2009-04-17
WO2008039052A8 (es) 2009-05-07
CR10685A (es) 2009-05-22

Similar Documents

Publication Publication Date Title
MX300732B (es) Celulasas, acidos nucleicos que las codifican y metodos para hacerlas y usarlas.
BRPI0714876A2 (pt) glucanases, ácidos nucleicos codificando as mesmas e métodos para fabricar e usar as mesmas.
BRPI0822078A2 (pt) Método, e, sistema.
BRPI0813914A2 (pt) Sistema, e, método.
BRPI0917120A2 (pt) método, e, meio legível por computador.
BRPI0815494A2 (pt) Método implementado por computador, e, sistema.
EP2028172A4 (en) PROCESS FOR PRODUCING 1,3,3,3-TETRAFLUOROPROPENE
BRPI0818772A2 (pt) Dispositivo, método, e, meio legível por computador.
BRPI0906086A2 (pt) Método, sistemas e meio legível por computador.
BRPI0820122A2 (pt) Método de otimização de produção de poços, sistema, e método.
BRPI0911767A2 (pt) Processo, e, composto.
BRPI0916942A2 (pt) método, e, particulado do aditivo contra perda de fluido.
BRPI0810190A2 (pt) Sistema, e, método.
BRPI0820365A2 (pt) Método, sistema, e, mídia de armazenamento legível por computador.
BRPI0811236A2 (pt) Embarcação, e, método de amarração.
NO346368B1 (no) En fremgangsmåte for konsentrasjon av alfa-mannosidase.
BRPI1007504A2 (pt) método para pré-carregar um sistema de catamarã, e, sistema de catamarã.
BRPI0811342A2 (pt) "tampão e método de fabricação de um tampão em forma cilíndrica".
BRPI0814977A2 (pt) Sistema, e, método.
BRPI0815834A2 (pt) Método, caixa automático, e, sistema.
CL2007002760A1 (es) Metodo de estabilizacion de famotidina, que comprende realizarla en medios alcalinos con un ph superior a 8 mediante un proceso de microencapsulacion.
BRPI0719706A2 (pt) Processo para a preparação do 1,3-propanodiol.
BRPI0812871A2 (pt) " recipiente, e, método para formar o mesmo ".
WO2008022033A3 (en) Methods for preventing or treating cardiovascular disease
BRPI0916887A2 (pt) método, meio legível por máquina, e, sistema